Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nabulsi Azmi
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Molly
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KARBE FRANK
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Parikh Asit
Phathom Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Jennison Associates LLC(10.4%)
Phathom Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(18.0%),Patrick J. Heron(18.0%), etc.
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nabulsi Azmi
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Molly
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Curran Terrie
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(17.4%),Patrick J. Heron(17.3%), etc.
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Molly
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nabulsi Azmi
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KARBE FRANK
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Topper James N
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Parikh Asit
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director COLA MICHAEL F
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FIELDS HEIDI
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KARBE FRANK
No Data